All Stories

  1. Letter to the Editor for Hawley et al. UMB 2025:51(3);415-427
  2. Overview of Diagnostic Ultrasound Safety
  3. Optimization of measurements with an ultrasound attenuation coefficient algorithm for quantifying liver fat
  4. Invited Commentary: Ancillary US of the Bowel for Improved Patient Care and Management
  5. Deep Learning Model for Breast Shear Wave Elastography to Improve Breast Cancer Diagnosis (INSPiRED 006): An International, Multicenter Analysis
  6. A Nurses Guide to Contrast Enhanced Ultrasound
  7. The State of the Journal of Ultrasound in Medicine in 2024
  8. US Screening for Liver Lesions in Patients at Risk for HCC: How Well Does LI-RADS US Scoring System Perform?
  9. Intersystem and Interoperator Agreement of US Attenuation Coefficient for Quantifying Liver Steatosis
  10. Assessing Quality of Ultrasound Attenuation Coefficient Results for Liver Fat Quantification
  11. Ultrasound evaluation of chronic liver disease
  12. Letter to the Editor: “Altered probe pressure and body position increase diagnostic accuracy for men and women in detecting hepatic steatosis using quantitative ultrasound”
  13. Ultrasound backscatter coefficient for fat quantification is affected by the measurement depth
  14. Evaluation of Liver Stiffness Values Requires Consideration of Many Factors
  15. Contrast-enhanced US for HCC: Finally out from the waiting list?
  16. Breast elastography: how does it works, and for what purposes?
  17. Contrast-enhanced ultrasound: the ideal contrast imaging study for pregnant patients
  18. Toward acquisition protocol standardization for estimating liver fat content using ultrasound attenuation coefficient imaging
  19. Liver Fibrosis, Fat, and Iron Evaluation with MRI and Fibrosis and Fat Evaluation with US: A Practical Guide for Radiologists
  20. Screening for Hepatocellular Carcinoma:Image Quality Is Everything!
  21. State of the Journal: The JUM in 2022
  22. Liver Fat Quantification With Ultrasound
  23. New Technologies in the Assessment of Carotid Stenosis: Beyond the Color-Doppler Ultrasound—High Frame Rate Vector-Flow and 3D Arterial Analysis Ultrasound
  24. Ultrasound shear wave elastography for the evaluation of renal pathological changes in adult patients
  25. Potential of Lesion‐to‐Fat Elasticity Ratio Measured by Shear Wave Elastography to Reduce Benign Biopsies in BI‐RADS 4 Breast Lesions
  26. Long‐Term Follow‐Up of Non‐Enhancing Renal Masses on CEUS
  27. Deep learning‐based multimodal fusion network for segmentation and classification of breast cancers using B‐mode and elastography ultrasound images
  28. Interpreting Liver Stiffness Values in Clinical Practice: Is Histologic Classification Necessary for Clinical Relevance?
  29. Intelligent multi-modal shear wave elastography to reduce unnecessary biopsies in breast cancer diagnosis (INSPiRED 002): a retrospective, international, multicentre analysis
  30. Editorial Comment: How Imaging Can Manage the Fatty Liver Epidemic
  31. Shear wave elastography as a supplemental tool in the assessment of unsuspicious axillary lymph nodes in patients undergoing breast ultrasound examination
  32. Increasing CEUS utilization in the USA: a call to action for the adult and pediatric body imaging community
  33. Nebulizer use in tobacco-exposed SPIROMICS participants with or at risk of COPD
  34. Quantitative CT emphysema subtypes and pulmonary blood volume on dual-energy CT: The MESA Lung Study
  35. Race/ethnic, social, environmental, and genetic correlates to lung function decline: the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study
  36. The Urgent Need for FDA to Approve a Whole‐Body Application of Ultrasound Contrast Agents
  37. State of the Journal 2022
  38. US-targeted Microbubbles to Assess Liver Fibrosis
  39. Contrast Enhanced Ultrasound Compared with MRI and CT in the Evaluation of Post-Renal Transplant Complications
  40. How to perform shear wave elastography. Part II
  41. Diagnostic Accuracy of Shear-Wave Elastography for Breast Lesion Characterization in Women: A Systematic Review and Meta-Analysis
  42. US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative
  43. The importance of multi-modal imaging and clinical information for humans and AI-based algorithms to classify breast masses (INSPiRED 003): an international, multicenter analysis
  44. How to perform shear wave elastography. Part I
  45. Abstract PD11-05: Intelligent shear-wave elastography to reduce unnecessary biopsies in breast cancer diagnosis (INSPiRED 002): An international, multicenter analysis
  46. Bi-Modal Transfer Learning for Classifying Breast Cancers via Combined B-Mode and Ultrasound Strain Imaging
  47. The potential of combined shear wave and strain elastography to reduce unnecessary biopsies in breast cancer diagnostics – An international, multicentre trial
  48. Reasons why referring doctors order renal ultrasound contrast studies
  49. Outcomes of Return to Routine Screening for BI-RADS 3 Lesions Detected at Supplemental Automated Whole-Breast Ultrasound in Women With Dense Breasts: A Prospective Study
  50. A Pre‐Release Algorithm With a Confidence Map for Estimating the Attenuation Coefficient for Liver Fat Quantification
  51. Ocular Ultrasound
  52. Use of lumason/sonovue in contrast-enhanced ultrasound of the kidney for characterization of renal masses—a meta-analysis
  53. Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper
  54. Your “Sweet Spot” May Not Be So Sweet for Me
  55. The Potential of Shear Wave Elastography to Reduce Unnecessary Biopsies in Breast Cancer Diagnosis: An International, Diagnostic, Multicenter Trial
  56. Assessment of chronic liver disease by multiparametric ultrasound: results from a private practice outpatient facility
  57. Conventional ultrasound for diagnosis of hepatic steatosis is better than believed
  58. Dose‐Lowering in Contrast‐Enhanced MRI of the Central Nervous System: A Retrospective, Parallel‐Group Comparison Using Gadobenate Dimeglumine
  59. First proof-of-concept evaluation of the FUSION-X-US-II prototype for the performance of automated breast ultrasound in healthy volunteers
  60. A New Practical Decision Rule to Better Differentiate BI‐RADS 3 or 4 Breast Masses on Breast Ultrasound
  61. Are Race and Ethnicity Necessary to Define 'Normal' Lung Function? The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study
  62. Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort
  63. Quantification of Liver Steatosis: Is CT Equivalent to PDFF?
  64. The Underrated Role of Ultrasound in Peritoneal Dialysis
  65. First Proof-of-concept Evaluation of the FUSION-X-US-II Prototype for the Performance of Automated Breast Ultrasound in Healthy Volunteers
  66. Editor's Letter: State of the Journal
  67. Radiological Society of North America/Quantitative Imaging Biomarker Alliance Shear Wave Speed Bias Quantification in Elastic and Viscoelastic Phantoms
  68. Characterisation of Prostate Lesions Using Transrectal Shear Wave Elastography (SWE) Ultrasound Imaging: A Systematic Review
  69. Evaluation of the FUSION-X-US-II prototype to combine automated breast ultrasound and tomosynthesis
  70. Novel Approaches to Screening for Breast Cancer
  71. Genetic and non-genetic factors affecting the expression of COVID-19 relevant genes in the large airway epithelium
  72. Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver–Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS
  73. Elastography for Pediatric Chronic Liver Disease: A Review and Expert Opinion
  74. Contrast-enhanced Ultrasound—State of the Art in North America
  75. Contrast -Enhanced Ultrasound
  76. Contrast-Enhanced Ultrasonography of the Abdomen
  77. Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement
  78. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2020 – WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS
  79. Evaluation of the Reproducibility of Bolus Transit Quantification With Contrast-Enhanced Ultrasound Across Multiple Scanners and Analysis Software Packages—A Quantitative Imaging Biomarker Alliance Study
  80. Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy: Is shear wave elastography a useful tool in clinical routine?
  81. Ultrasound liver elastography beyond liver fibrosis assessment
  82. Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid
  83. Characterization and clinical course of 1000 patients with COVID-19 in New York: retrospective case series
  84. Advanced ultrasound in the diagnosis of prostate cancer
  85. Benefits, Open questions and Challenges of the use of Ultrasound in the COVID-19 pandemic era. The views of a panel of worldwide international experts
  86. Abstract P151: Race/ethnic Differences in Six Minute Walk Distance Among Older Adults: The Multi-ethnic Study of Atherosclerosis
  87. AIUM Practice Parameter for the Performance of Contrast‐Enhanced Ultrasound Examinations
  88. Breast elastography
  89. Can Accurate Shear Wave Velocities Be Obtained in Kidneys?
  90. Breast Elastography: How to Perform and Integrate Into a “Best‐Practice” Patient Treatment Algorithm
  91. 2-D Shear wave dispersion images using the reverberant shear wave field approach: application in tissues exhibiting power law response
  92. An initial study of complete 2D shear wave dispersion images using a reverberant shear wave field
  93. Letter to the Editor
  94. Ultrasound of Diffuse Liver Disease Including Elastography
  95. Use of a Real‐Time Stress Map for Assessment of Applied Stress for Strain Elastography: Utility in Training and Computation of Strain Ratios
  96. Future of breast elastography
  97. Just Because There is a Button Doesn't Mean it is Appropriate to Use or That it will Give Accurate Information
  98. A Clinical Study Comparing the Diagnostic Performance of Assist Strain Ratio Against Manual Strain Ratio in Ultrasound Breast Elastography
  99. Passing of the Transducer
  100. Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations
  101. Diagnostic Performance and Accuracy of the 3 Interpreting Methods of Breast Strain Elastography: A Systematic Review and Meta‐analysis
  102. Editorial Comment
  103. Gastric Lipoma
  104. Liver Elastography Still in Its Infancy
  105. Initial results of the FUSION-X-US prototype combining 3D automated breast ultrasound and tomosynthesis
  106. Evaluation of Inter-System Variability in Liver Stiffness Measurements
  107. Focal Liver Lesions: Computer-aided Diagnosis by Using Contrast-enhanced US Cine Recordings
  108. Contrast-Enhanced Ultrasound-Guided Radiofrequency Ablation of Renal Tumo
  109. The Role of Sonoelastography in Breast Lesions
  110. Initial results of the FUSION-X-US prototype combining 3D automated breast ultrasound and digital breast tomosynthesis
  111. How to perform Contrast-Enhanced Ultrasound (CEUS)
  112. Artifacts in contrast-enhanced ultrasound: a pictorial essay
  113. Shear wave liver elastography
  114. Strain Elastography - How To Do It?
  115. Contrast enhanced ultrasound for focal liver lesions: how accurate is it?
  116. Agreement Between an Automated Volume Breast Scanner and Handheld Ultrasound for Diagnostic Breast Examinations
  117. Thyroid Ultrasound: State of the Art. Part 2 – Focal Thyroid Lesions
  118. Ultrasound Elastography of the Liver: What the Clinician Needs to Know
  119. A Case Study of Hemochromatosis and Conflicting Point Shear Wave Measurements in the Assessment of Liver Fibrosis
  120. Primary Angiosarcoma of the Breast
  121. How to Develop a Contrast-Enhanced Ultrasound Program
  122. Thyroid Ultrasound: State of the Art Part 1 – Thyroid Ultrasound reporting and Diffuse Thyroid Diseases
  123. Is There a Need to Modify the Bosniak Renal Mass Classification With the Addition of Contrast-Enhanced Sonography?
  124. Foreword to the Second Set of WFUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography
  125. WFUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography: Part 4. Thyroid
  126. WFUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography: Part 5. Prostate
  127. Compression with transducer effects breast blood flow
  128. Invited Commentary on “Elastography in Chronic Liver Disease”
  129. Sonoelastography of Breast Lymphoma
  130. Sonographic Elastography of Mastitis
  131. Elastography Assessment of Liver Fibrosis
  132. Richard G Barr. Breast ElastographyBarrRichard G. Breast Elastography. New York, USA: Thieme Medical Publishers Inc, 2015. ISBN: 9781604068528; 192 pp.: £68.50 (hbk)
  133. Consensus on Elastography of the Liver
  134. Transcutaneous Ultrasound: Elastographic Lymph Node Evaluation. Current Clinical Applications and Literature Review
  135. RSNA QIBA ultrasound shear wave speed Phase II phantom study in viscoelastic media
  136. Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement
  137. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 2: Breast
  138. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 3: Liver
  139. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 1: Basic Principles and Terminology
  140. Prostate Cancer: Diagnostic Performance of Real-time Shear-Wave Elastography
  141. Shear-Wave Elastography of the Breast: Value of a Quality Measure and Comparison with Strain Elastography
  142. Clinical application of sonoelastography in thyroid, prostate, kidney, pancreas, and deep venous thrombosis
  143. Breast Elastography
  144. 2 elastographyPrinciples of Elastography
  145. 1 -elastographyIntroduction to Breast Elastography
  146. 3 strain elastography (SE)Strain Elastography
  147. 4 shear wave elastography (SWE)Shear Wave Elastography
  148. 6 benign lesionsClinical Cases: Benign Lesions
  149. 7 malignant lesionsClinical Cases: Malignant Lesions
  150. 8 lesionsClinical Cases of Other Lesions
  151. 9 elastographyFuture Perspective and Conclusions
  152. 5 strain elastography (SE)combined with shear wave elastographyshear wave elastography (SWE)combined with strain elastographyCombination of Shear Wave and Strain Elastography
  153. Breast Elastography
  154. Elastography in Clinical Practice
  155. Elastography of the Abdomen
  156. Evaluation of Indeterminate Renal Masses with Contrast-enhanced US: A Diagnostic Performance Study
  157. Incidental Detection of an Aortic Stent Endoleak With Contrast-Enhanced Sonography
  158. Strain Elastography for Prediction of Breast Cancer Tumor Grades
  159. Probably Benign Lesions at Screening Breast US in a Population with Elevated Risk: Prevalence and Rate of Malignancy in the ACRIN 6666 Trial
  160. US Elastography: Applications in Tumors
  161. Lung Cancer Metastatic to Breast
  162. RSNA/QIBA: Shear wave speed as a biomarker for liver fibrosis staging
  163. Artifacts in diagnostic ultrasound
  164. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2012
  165. Off-Label Use of Ultrasound Contrast Agents for Abdominal Imaging in the United States
  166. Contrast-Enhanced Ultrasound-Guided Radiofrequency Ablation of Renal Tumors
  167. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2012
  168. Speed of Sound Correction and Quality Control
  169. Supplementary Imaging for Breast Cancer Screening in High-Risk Women—Reply
  170. Improved Needle Visualization With Electronic Beam Steering
  171. Effects of Precompression on Elasticity Imaging of the Breast
  172. Sonographic Breast Elastography
  173. Detection of Breast Cancer With Addition of Annual Screening Ultrasound or a Single Screening MRI to Mammography in Women With Elevated Breast Cancer Risk
  174. Shear Wave Ultrasound Elastography of the Prostate
  175. Shear Wave Imaging of the Breast
  176. The Utility of the “Bull’s-Eye” Artifact on Breast Elasticity Imaging in Reducing Breast Lesion Biopsy Rate
  177. Evaluation of Breast Lesions Using Sonographic Elasticity Imaging
  178. The Utility of the "Bull's-Eye" Artifact on Breast Elasticity Imaging in Reducing Breast Lesion Biopsy Rate
  179. Mesothelioma of tunica vaginalis of "uncertain malignant potential" - an evolving concept: case report and review of the literature
  180. Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial
  181. The National Lung Screening Trial: Overview and Study Design
  182. Real-Time Ultrasound Elasticity of the Breast
  183. Reasons Women at Elevated Risk of Breast Cancer Refuse Breast MR Imaging Screening: ACRIN 6666
  184. Contrast-Enhanced Ultrasound Detection and Treatment Guidance in a Renal Transplant Patient With Renal Cell Carcinoma
  185. US Elastography of Breast and Prostate Lesions1
  186. Comparison of Conventional, Compounding, Computer Enhancement, and Compounding With Computer Enhancement in Ultrasound Imaging of the Breast
  187. Comparison of Sonography and Scintigraphy in the Evaluation of Gallbladder Functional Studies With Cholecystokinin
  188. Speed of Sound Imaging
  189. Dynamic Automatic Ultrasound Optimization
  190. Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer
  191. Meta-analysis of laparoscopic and open distal gastrectomy for gastric carcinoma
  192. Duplex Doppler Sonography of the Carotid Artery
  193. In situ measurements of orange roughy (Hoplostethus atlanticus) target strength
  194. Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity
  195. Renal imaging with ultrasound contrast
  196. Gastroesophageal reflux disease (GERD) and asthma in women
  197. Seeking Consensus
  198. Seeking consensus: contrast ultrasound in radiology
  199. A Clinical Comparison of the Safety and Efficacy of MultiHance (Gadobenate Dimeglumine) and Omniscan (Gadodiamide) in Magnetic Resonance Imaging in Patients with Central Nervous System Pathology
  200. Evaluation of Renal Pathology With an Intravenous Ultrasound Contrast Agent
  201. Significance of Minimal or No Intraperitoneal Fluid Visible on CT Scan Associated with Blunt Liver and Splenic Injuries: A Multicenter Analysis
  202. Contrast-Enhanced Sonography in Patients with Renal Pathology
  203. Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function
  204. Run-in Periods in Randomized Trials
  205. ELF and VLF wave generation by HF heating: A comparison of AM and CW techniques
  206. Acalculous gallbladder disease: US evaluation after slow-infusion cholecystokinin stimulation in symptomatic and asymptomatic adults.
  207. Nonadherence in Tuberculosis Treatment: Predictors and Consequences in New York City
  208. Reflection of VLF radio waves from the Canadian Rockies
  209. Ethidium Bromide Binding to Unstructured and Structured 2′ GMP
  210. A simple theoretical model for computing omega navigation errors near Antarctica
  211. Extracorporeal liver and spleen in gastroschisis.
  212. Structure Sensitivity of Amino Proton Exchange in 2′ - and 5′ - Guanosine Monophosphate Dianions
  213. Collaborative experiments by Akebono satellite, Tromsø ionospheric heater, and European incoherent scatter radar
  214. A simple theoretical model of the diffraction of VLF electromagnetic waves by the Antarctic icecap
  215. Proton NMR imaging of cerebral blood flow using H217O
  216. The stability of protonT2 effects of oxygen-17 water in experimental cerebral ischemia
  217. Bilateral renal masses in a 61-year-old man
  218. Renal tissue within the adrenal gland simulating an adrenal mass.
  219. Oxygen-17 Contrast Agents Fast Imaging Techniques
  220. Oxygen-17 Contrast Agents Fast Imaging Techniques
  221. Improved sensitivity of proton MR to oxygen-17 as a contrast agent using fast imaging: Detection in brain
  222. Physiological Application of17O Promoted Proton T2Relaxation
  223. Oxygen-17 compounds as potential NMRT2 contrast agents: Enrichment effects of H217O on protein solutions and living tissues
  224. The significance of fast imaging methods to oxygen-17 based contrast agents
  225. Solution ordering of guanosine 2'-monophosphate dianions with alkali metal ions as structure directors
  226. Fasting breath hydrogen concentration: Normal values and clinical application
  227. Ordered forms of dianionic guanosine 5'-monophosphate with sodium ion as the structure director. Proton and phosphorus-31 NMR studies of hydrogen bonding and comparisons of stacked tetramer and stacked dimer models
  228. 31P NMR studies of energy metabolism in perfused rat kidney
  229. Some new features of ELF attenuation
  230. The effect of the Earth's magnetic field on the propagation of ELF and VLF radio waves
  231. The propagation of ELF and VLF radio waves beneath an inhomogeneous anisotropic ionosphere
  232. The attenuation of ELF and VLF radio waves propagating below inhomogeneous isotropic ionospheres
  233. The ELF and VLF amplitude spectrum of atmospherics with particular reference to the attenuation band near 3 kHz
  234. POLLY I: Operator‐Assisted Bubble Chamber Film Measuring System